|
1
|
Krishnan K: Chapter 1 - Introduction to
Big Data. Data Warehousing in the Age of Big Data. Krishnan K:
Morgan Kaufmann; Boston, MA: pp. 3–14. 2013, View Article : Google Scholar
|
|
2
|
Bier G, Klumpp B, Roder C, Garbe C,
Preibsch H, Ernemann U and Hempel JM: Meningeal enhancement
depicted by magnetic resonance imaging in tumor patients:
Neoplastic meningitis or therapy-related enhancement?
Neuroradiology. 61:775–782. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gavrilovic IT and Posner JB: Brain
metastases: Epidemiology and pathophysiology. J Neurooncol.
75:5–14. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fazekas F, Chawluk JB, Alavi A, Hurtig HI
and Zimmerman RA: MR signal abnormalities at 1.5 T in Alzheimer's
dementia and normal aging. AJR Am J Roentgenol. 149:351–356. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Boire A, Zou Y, Shieh J, Macalinao DG,
Pentsova E and Massagué J: Complement component 3 adapts the
cerebrospinal fluid for leptomeningeal metastasis. Cell.
168:1101–1113.e3. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nayak L, Fleisher M, Gonzalez-Espinoza R,
Lin O, Panageas K, Reiner A, Liu CM, Deangelis LM and Omuro A: Rare
cell capture technology for the diagnosis of leptomeningeal
metastasis in solid tumors. Neurology. 80:1598–1605; discussion
1603. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nayar G, Ejikeme T, Chongsathidkiet P,
Elsamadicy AA, Blackwell KL, Clarke JM, Lad SP and Fecci PE:
Leptomeningeal disease: current diagnostic and therapeutic
strategies. Oncotarget. 8:73312–73328. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Le Rhun E, Taillibert S, Boulanger T,
Zairi F, Bonneterre J and Chamberlain MC: Prolonged response and
restoration of functional independence with bevacizumab plus
vinorelbine as third-line treatment for breast cancer-related
leptomeningeal metastases. Case Rep Oncol. 8:72–77. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cacho-Díaz B, Lorenzana-Mendoza NA,
Chávez-Hernandez JD, González-Aguilar A, Reyes-Soto G and
Herrera-Gómez Á: Clinical manifestations and location of brain
metastases as prognostic markers. Curr Probl Cancer. 43:312–323.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Noh T and Walbert T: Brain metastasis:
clinical manifestations, symptom management, and palliative care.
Handb Clin Neurol. 149:75–88. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nguyen A, Nguyen A, Dada OT, Desai PD,
Ricci JC, Godbole NB, Pierre K and Lucke-Wold B: Leptomeningeal
metastasis: A review of the pathophysiology, diagnostic
methodology, and therapeutic landscape. Curr Oncol. 30:5906–5931.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ferguson SD, Bindal S, Bassett RJ, Haydu
LE, Mccutcheon IE, Heimberger AB, Li J, O'Brien BJ, Guha-Thakurta
N, Tetzlaff MT, et al: Predictors of survival in metastatic
melanoma patients with leptomeningeal disease (LMD). J Neurooncol.
142:499–509. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chatterjee S, Saini J, Kesavadas C,
Arvinda HR, Jolappara M and Gupta AK: Differentiation of tubercular
infection and metastasis presenting as ring enhancing lesion by
diffusion and perfusion magnetic resonance imaging. J Neuroradiol.
37:167–171. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Le Rhun E, Weller M, Brandsma D, Van den
Bent M, de Azambuja E, Henriksson R, Boulanger T, Peters S, Watts
C, Wick W, et al: EANO-ESMO clinical practice guidelines for
diagnosis, treatment and follow-up of patients with leptomeningeal
metastasis from solid tumours. Ann Oncol. 28 (Suppl_4):iv84–iv99.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Su X and Wei D: Four cases of meningeal
metastatic melanoma. Chin J Contemp Neurol Neurosurg. 8:485–486.
2008.(In Chinese).
|
|
16
|
Steininger J, Gellrich FF, Engellandt K,
Meinhardt M, Westphal D, Beissert S, Meier F and Glitza Oliva IC:
Leptomeningeal metastases in melanoma patients: An update on and
future perspectives for diagnosis and treatment. Int J Mol Sci.
24:114432023. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Clarke JL, Perez HR, Jacks LM, Panageas KS
and Deangelis LM: Leptomeningeal metastases in the MRI era.
Neurology. 74:1449–1454. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gleissner B and Chamberlain MC: Neoplastic
meningitis. Lancet Neurol. 5:443–452. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Corovic A, Kelly S and Markus HS: Cerebral
amyloid angiopathy associated with inflammation: A systematic
review of clinical and imaging features and outcome. Int J Stroke.
13:257–267. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Piña Y, Yadugiri S, Yeboa DN, Ferguson SD,
Forsyth PA and Oliva I: Advances in diagnosis and treatment for
leptomeningeal disease in melanoma. Curr Oncol Rep. 24:43–54. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lara-Medina F, Crismatt A,
Villarreal-Garza C, Alvarado-Miranda A, Flores-Hernández L,
González-Pinedo M, Gamboa-Vignolle C, Ruiz-González JD and Arrieta
O: Clinical features and prognostic factors in patients with
carcinomatous meningitis secondary to breast cancer. Breast J.
18:233–241. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Morris PG, Reiner AS, Szenberg OR, Clarke
JL, Panageas KS, Perez HR, Kris MG, Chan TA, Deangelis LM and Omuro
AM: Leptomeningeal metastasis from non-small cell lung cancer:
survival and the impact of whole brain radiotherapy. J Thorac
Oncol. 7:382–385. 2012. View Article : Google Scholar : PubMed/NCBI
|
